Lei Gong

机构：Tianjin Medical University Cancer Institute and Hospital · ORCID：0000-0001-6897-2533

发表论文 179 篇 · 总被引 4456 次 · h-index 32

代表论文

• Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial (2025 · The Lancet Oncology · 被引 32)
• Preliminary results from the multicenter, randomized phase III trial (SCIENCE): Comparing chemotherapy plus sintilimab and chemoradiotherapy plus sintilimab versus chemoradiotherapy for neoadjuvant treatment in resectable locally advanced esophageal squamous cell carcinoma. (2025 · Journal of Clinical Oncology · 被引 10)
• Mendelian randomization in Alzheimer’s disease and mild cognitive impairment: Hippocampal volume associations (2024 · Neuroscience · 被引 6)
• Longitudinal analysis of cytokine dynamics in severe fever with thrombocytopenia syndrome patients — High-incidence regions of China (2010–2023) (2025 · Biosafety and Health · 被引 5)
• Integrated machine learning developed a prognosis‐related gene signature to predict prognosis in oesophageal squamous cell carcinoma (2024 · Journal of Cellular and Molecular Medicine · 被引 4)
• Multi‐Institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma (2025 · Cancer Medicine · 被引 3)